What do people think will be Acadia 's Strategy concerning Rett's and their recently acquired NNZ compound which appears far less side effects and little no diarrhoea which seems to be a significant impediment to getting more penetration and increasing retention? If population is at least 6000 and can get 75% penetration and 80% retention you are looking at sales of about 1.5 billion
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.31 |
Change
-0.790(3.93%) |
Mkt cap ! $2.436B | |||
| Open | High | Low | Value | Volume |
| $19.86 | $19.99 | $17.97 | $22.65M | 1.195M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2222 | $19.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.31 | 8162 | 3 |
View Market Depth
| Last trade - 16.10pm 09/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$19.25 |
Change
-0.790 ( 4.18 %) |
||||
| Open | High | Low | Volume | ||
| $19.88 | $19.88 | $17.97 | 249066 | ||
| Last updated 15.59pm 09/05/2024 ? | |||||
| NEU (ASX) Chart |